Protagonist Therapeutics (PTGX) CEO sells 100,000 shares after option exercise
Protagonist Therapeutics President and CEO Dinesh V. Patel exercised stock options for 100,000 shares at $21.58 each and subsequently sold all 100,000 shares in open-market transactions on August 10-11, 2026. The sales, conducted under a Rule 10b5-1 trading plan, generated approximately $14.89 million in …